article Open AccessTop 1% cited

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

Annals of Oncology · 2014 · Vol. 26(2) · pp. 259–271

Roberto Salgado(Institut Jules Bordet)Carsten Denkert(Charité - Universitätsmedizin Berlin)Sandra Demaria(New York University)Nicolas Sirtaine(Université Libre de Bruxelles)Frederick Klauschen(Charité - Universitätsmedizin Berlin)Giancarlo Pruneri(University of Milan)Stephan Wienert(Charité - Universitätsmedizin Berlin)Gert Van den Eynden(Antwerp University Hospital)Frederick L. Baehner(University of California, San Francisco)Frédérique Penault‐Llorca(Centre Jean Perrin)Edith A. PerezE. Aubrey Thompson(Mayo Clinic in Florida)W. Fraser Symmans(The University of Texas MD Anderson Cancer Center)Andrea L. Richardson(Brigham and Women's Hospital)Jane Brock(Harvard University)Carmen Criscitiello(European Institute of Oncology)Helen D. Bailey(Genomic Health (United States))M. Ignatiadis(Université Libre de Bruxelles)Giuseppe Floris(KU Leuven)Joseph A. Sparano(Einstein Medical Center Philadelphia)Zuzana Kos(University Health Network)Torsten O. Nielsen(University of British Columbia)David L. Rimm(Yale University)Kimberly H. Allison(Stanford University)Jorge S. Reis‐Filho(Memorial Sloan Kettering Cancer Center)Sibylle Loibl(German Breast group)Christos Sotiriou(Université Libre de Bruxelles)Giuseppe Viale(University of Milan)Sunil Badve(Indiana University – Purdue University Indianapolis)Sylvia Adams(New York University)Karen Willard‐Gallo(Université Libre de Bruxelles)Sherene Loi✉(The University of Melbourne)

Cancer Immunotherapy and Biomarkers Immune cells in cancer Inflammatory Biomarkers in Disease PrognosisMedicineTumor-infiltrating lymphocytesH&E stainBreast cancerOncologyMedical physicsCancerPathologyInternal medicineImmunotherapy